ArticleJournal of diabetes and metabolic disorders2024
The clinical effectiveness of telemedicine for managing type 2 diabetes in India: a meta-analysis of the impact of telemedicine with clinic visits.
Article in Journal of diabetes and metabolic disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Telemedicine has emerged as a promising solution for enhancing Type 2 diabetes management, which aims to reduce healthcare costs and improve patient outcomes. Despite its potential benefits for diabetes management in India, knowledge of its clinical effectiveness is scarce. This meta-analysis examines the clinical effectiveness of telemedicine versus physical consultation in managing Type 2 diabetes in India. Methods: The meta-analysis adhered to the PRISMA-P guidelines and was registered with PROSPERO (CRD42023400562). PubMed and EMBASE were searched for eligible studies from 1st January 2012 to 30th June 2022. Included were studies on Type 2 diabetes patients in India comparing telemedicine (Intervention) with physical consultation (conventional) regarding effect on HbA1c changes. Risk of bias for randomised studies of Intervention (RoB-2) was used for study quality assessment. Results: We found four articles that met the eligibility criteria, all reporting quantitative HbA1c change. The telemedicine interventions included video consultation, health systemcomputer-generated telephonic messages and a Video-Based Lifestyle Education Programme. Upon pooling the results from these studies, an overall analysis indicated a non-statistically significant reduction in HbA1c levels following the intervention compared to conventional treatment (pooled difference in means = -0.03, 95% CI = -0.23 to 0.17, Z = 0.30 Conclusion: Enhancing telemedicine approaches may hold promise in improving type 2 diabetes management in India, although the existing evidence remains inconclusive. Further research involving long-term telemedicine interventions would help to provide more substantial evidence on the clinical effectiveness of telemedicine for Type 2 diabetes management in India. Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-024-01471-x.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.